vs
欧加隆（OGN）与泰瑞达（TER）财务数据对比。点击上方公司名可切换其他公司
欧加隆的季度营收约是泰瑞达的1.4倍（$1.5B vs $1.1B），泰瑞达净利率更高（23.7% vs -13.6%，领先37.3%），泰瑞达同比增速更快（43.9% vs -5.3%），泰瑞达自由现金流更多（$218.8M vs $96.0M），过去两年泰瑞达的营收复合增速更高（34.4% vs -3.6%）
欧加隆是一家总部位于美国新泽西州泽西城的制药企业，核心业务覆盖生殖医学、避孕、精神科、激素替代疗法及麻醉领域的药物研发与生产。公司所有产品均在美国境外生产，同时美国市场贡献了其三分之一的营收。
泰瑞达是总部位于美国马萨诸塞州北雷丁的自动测试设备（ATE）设计及制造企业，在全球半导体测试领域拥有深厚技术积累，服务的知名客户涵盖三星、高通、英特尔、亚德诺、德州仪器、IBM等行业头部企业。
OGN vs TER — 直观对比
营收规模更大
OGN
是对方的1.4倍
$1.1B
营收增速更快
TER
高出49.2%
-5.3%
净利率更高
TER
高出37.3%
-13.6%
自由现金流更多
TER
多$122.8M
$96.0M
两年增速更快
TER
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.1B |
| 净利润 | $-205.0M | $257.2M |
| 毛利率 | 49.2% | 57.2% |
| 营业利润率 | -9.8% | 27.1% |
| 净利率 | -13.6% | 23.7% |
| 营收同比 | -5.3% | 43.9% |
| 净利润同比 | -288.1% | 75.9% |
| 每股收益（稀释后） | $-0.78 | $1.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OGNTER
| Q4 25 | $1.5B | $1.1B | ||
| Q3 25 | $1.6B | $769.2M | ||
| Q2 25 | $1.6B | $651.8M | ||
| Q1 25 | $1.5B | $685.7M | ||
| Q4 24 | $1.6B | $752.9M | ||
| Q3 24 | $1.6B | $737.3M | ||
| Q2 24 | $1.6B | $729.9M | ||
| Q1 24 | $1.6B | $599.8M |
净利润OGNTER
| Q4 25 | $-205.0M | $257.2M | ||
| Q3 25 | $160.0M | $119.6M | ||
| Q2 25 | $145.0M | $78.4M | ||
| Q1 25 | $87.0M | $98.9M | ||
| Q4 24 | $109.0M | $146.3M | ||
| Q3 24 | $359.0M | $145.6M | ||
| Q2 24 | $195.0M | $186.3M | ||
| Q1 24 | $201.0M | $64.2M |
毛利率OGNTER
| Q4 25 | 49.2% | 57.2% | ||
| Q3 25 | 53.5% | 58.4% | ||
| Q2 25 | 54.8% | 57.2% | ||
| Q1 25 | 55.6% | 60.6% | ||
| Q4 24 | 56.3% | 59.4% | ||
| Q3 24 | 58.3% | 59.2% | ||
| Q2 24 | 58.4% | 58.3% | ||
| Q1 24 | 59.0% | 56.6% |
营业利润率OGNTER
| Q4 25 | -9.8% | 27.1% | ||
| Q3 25 | 15.2% | 18.9% | ||
| Q2 25 | 14.4% | 13.9% | ||
| Q1 25 | 6.7% | 17.6% | ||
| Q4 24 | 8.1% | 20.4% | ||
| Q3 24 | 13.1% | 20.6% | ||
| Q2 24 | 14.6% | 28.8% | ||
| Q1 24 | 14.5% | 13.0% |
净利率OGNTER
| Q4 25 | -13.6% | 23.7% | ||
| Q3 25 | 10.0% | 15.5% | ||
| Q2 25 | 9.1% | 12.0% | ||
| Q1 25 | 5.8% | 14.4% | ||
| Q4 24 | 6.8% | 19.4% | ||
| Q3 24 | 22.7% | 19.8% | ||
| Q2 24 | 12.1% | 25.5% | ||
| Q1 24 | 12.4% | 10.7% |
每股收益（稀释后）OGNTER
| Q4 25 | $-0.78 | $1.62 | ||
| Q3 25 | $0.61 | $0.75 | ||
| Q2 25 | $0.56 | $0.49 | ||
| Q1 25 | $0.33 | $0.61 | ||
| Q4 24 | $0.42 | $0.89 | ||
| Q3 24 | $1.38 | $0.89 | ||
| Q2 24 | $0.75 | $1.14 | ||
| Q1 24 | $0.78 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $574.0M | $293.8M |
| 总债务越低越好 | $8.6B | — |
| 股东权益账面价值 | $752.0M | $2.8B |
| 总资产 | $12.9B | $4.2B |
| 负债/权益比越低杠杆越低 | 11.49× | — |
8季度趋势，按日历期对齐
现金及短期投资OGNTER
| Q4 25 | $574.0M | $293.8M | ||
| Q3 25 | $672.0M | $272.7M | ||
| Q2 25 | $599.0M | $339.3M | ||
| Q1 25 | $547.0M | $475.6M | ||
| Q4 24 | $675.0M | $553.4M | ||
| Q3 24 | $763.0M | $510.0M | ||
| Q2 24 | $704.0M | $421.9M | ||
| Q1 24 | $575.0M | $707.4M |
总债务OGNTER
| Q4 25 | $8.6B | — | ||
| Q3 25 | $8.8B | — | ||
| Q2 25 | $8.9B | — | ||
| Q1 25 | $9.0B | — | ||
| Q4 24 | $8.9B | — | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.7B | — | ||
| Q1 24 | $8.7B | — |
股东权益OGNTER
| Q4 25 | $752.0M | $2.8B | ||
| Q3 25 | $906.0M | $2.7B | ||
| Q2 25 | $733.0M | $2.8B | ||
| Q1 25 | $542.0M | $2.8B | ||
| Q4 24 | $472.0M | $2.8B | ||
| Q3 24 | $493.0M | $2.9B | ||
| Q2 24 | $144.0M | $2.7B | ||
| Q1 24 | $48.0M | $2.6B |
总资产OGNTER
| Q4 25 | $12.9B | $4.2B | ||
| Q3 25 | $13.6B | $4.0B | ||
| Q2 25 | $13.5B | $3.8B | ||
| Q1 25 | $13.2B | $3.7B | ||
| Q4 24 | $13.1B | $3.7B | ||
| Q3 24 | $12.8B | $3.8B | ||
| Q2 24 | $12.2B | $3.6B | ||
| Q1 24 | $11.9B | $3.4B |
负债/权益比OGNTER
| Q4 25 | 11.49× | — | ||
| Q3 25 | 9.74× | — | ||
| Q2 25 | 12.14× | — | ||
| Q1 25 | 16.52× | — | ||
| Q4 24 | 18.81× | — | ||
| Q3 24 | 17.75× | — | ||
| Q2 24 | 60.11× | — | ||
| Q1 24 | 181.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $141.0M | $281.6M |
| 自由现金流经营现金流 - 资本支出 | $96.0M | $218.8M |
| 自由现金流率自由现金流/营收 | 6.4% | 20.2% |
| 资本支出强度资本支出/营收 | 3.0% | 5.8% |
| 现金转化率经营现金流/净利润 | — | 1.09× |
| 过去12个月自由现金流最近4个季度 | $538.0M | $450.4M |
8季度趋势，按日历期对齐
经营现金流OGNTER
| Q4 25 | $141.0M | $281.6M | ||
| Q3 25 | $264.0M | $49.0M | ||
| Q2 25 | $220.0M | $182.1M | ||
| Q1 25 | $75.0M | $161.6M | ||
| Q4 24 | $390.0M | $282.6M | ||
| Q3 24 | $141.0M | $166.3M | ||
| Q2 24 | $332.0M | $216.1M | ||
| Q1 24 | $76.0M | $7.3M |
自由现金流OGNTER
| Q4 25 | $96.0M | $218.8M | ||
| Q3 25 | $218.0M | $2.4M | ||
| Q2 25 | $181.0M | $131.7M | ||
| Q1 25 | $43.0M | $97.6M | ||
| Q4 24 | $335.0M | $225.2M | ||
| Q3 24 | $99.0M | $114.4M | ||
| Q2 24 | $300.0M | $171.2M | ||
| Q1 24 | $30.0M | $-36.7M |
自由现金流率OGNTER
| Q4 25 | 6.4% | 20.2% | ||
| Q3 25 | 13.6% | 0.3% | ||
| Q2 25 | 11.4% | 20.2% | ||
| Q1 25 | 2.8% | 14.2% | ||
| Q4 24 | 21.0% | 29.9% | ||
| Q3 24 | 6.3% | 15.5% | ||
| Q2 24 | 18.7% | 23.5% | ||
| Q1 24 | 1.8% | -6.1% |
资本支出强度OGNTER
| Q4 25 | 3.0% | 5.8% | ||
| Q3 25 | 2.9% | 6.1% | ||
| Q2 25 | 2.4% | 7.7% | ||
| Q1 25 | 2.1% | 9.3% | ||
| Q4 24 | 3.5% | 7.6% | ||
| Q3 24 | 2.7% | 7.0% | ||
| Q2 24 | 2.0% | 6.1% | ||
| Q1 24 | 2.8% | 7.3% |
现金转化率OGNTER
| Q4 25 | — | 1.09× | ||
| Q3 25 | 1.65× | 0.41× | ||
| Q2 25 | 1.52× | 2.32× | ||
| Q1 25 | 0.86× | 1.63× | ||
| Q4 24 | 3.58× | 1.93× | ||
| Q3 24 | 0.39× | 1.14× | ||
| Q2 24 | 1.70× | 1.16× | ||
| Q1 24 | 0.38× | 0.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OGN
暂无分部数据
TER
| Soc | $646.5M | 60% |
| Memory | $206.5M | 19% |
| Transferred At Point In Time | $90.0M | 8% |
| Universal Robots | $89.4M | 8% |
| IST | $30.5M | 3% |
| Transferred Over Time | $20.5M | 2% |
